Clinical Trial Update: Remote Monitoring of Vital Signs With Telehealth to Prevent Readmissions for Dysglycemia [NA]

View source ↗

Summary

A completed DexCom-sponsored study evaluated remote vital-sign monitoring with telehealth to prevent readmissions for dysglycemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dysglycemia

Drugs mentioned

• Dexcom Continuous Glucose Monitoring System

Snippet

Sponsor: DexCom, Inc. | Conditions: Dysglycemia | NA | Status: COMPLETED